These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30868380)

  • 21. Endpoints for relative effectiveness assessment (REA) of pharmaceuticals.
    Pavlovic M; Teljeur C; Wieseler B; Klemp M; Cleemput I; Neyt M
    Int J Technol Assess Health Care; 2014 Nov; 30(5):508-13. PubMed ID: 25747560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANALYSIS OF DUPLICATION AND TIMING OF HEALTH TECHNOLOGY ASSESSMENTS ON MEDICAL DEVICES IN EUROPE.
    Hawlik K; Rummel P; Wild C
    Int J Technol Assess Health Care; 2018 Jan; 34(1):18-26. PubMed ID: 29258630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
    Ciani O; Wilcher B; van Giessen A; Taylor RS
    Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key Recommendations from the MedtecHTA Project.
    Tarricone R; Torbica A; Drummond M;
    Health Econ; 2017 Feb; 26 Suppl 1():145-152. PubMed ID: 28139086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of medical devices.
    Banta HD
    Prev Med; 1990 Nov; 19(6):693-9. PubMed ID: 2263580
    [No Abstract]   [Full Text] [Related]  

  • 26. HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?
    Garattini L; Padula A
    Eur J Health Econ; 2020 Feb; 21(1):1-5. PubMed ID: 31440857
    [No Abstract]   [Full Text] [Related]  

  • 27. The HTA Core Model
    Kristensen FB; Lampe K; Wild C; Cerbo M; Goettsch W; Becla L
    Value Health; 2017 Feb; 20(2):244-250. PubMed ID: 28237203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.
    Polisena J; Castaldo R; Ciani O; Federici C; Borsci S; Ritrovato M; Clark D; Pecchia L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):276-289. PubMed ID: 29909792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The truth behind "made in Europe" labels on medical devices.
    Cohen D
    BMJ; 2012 Oct; 345():e7193. PubMed ID: 23097557
    [No Abstract]   [Full Text] [Related]  

  • 30. Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company.
    Ducournau P; Irl C; Tatt I; McCarvil M; Gyldmark M
    Int J Technol Assess Health Care; 2019 Jan; 35(1):10-16. PubMed ID: 30789111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.
    Garfield S; Polisena J; S Spinner D; Postulka A; Y Lu C; Tiwana SK; Faulkner E; Poulios N; Zah V; Longacre M
    Value Health; 2016; 19(5):577-87. PubMed ID: 27565275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a regulation of HTA in Europe: the proposal from the European Commission.
    Migliore A
    Expert Rev Med Devices; 2019 Jan; 16(1):1-2. PubMed ID: 30521405
    [No Abstract]   [Full Text] [Related]  

  • 33. Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment.
    Gonçalves E
    Eur J Health Econ; 2020 Apr; 21(3):311-320. PubMed ID: 31919703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital-based health technology assessment in France: A focus on medical devices.
    Martelli N; Puc C; Szwarcensztein K; ; Beuscart R; Coulonjou H; Degrassat-Théas A; Dutot C; Epis de Fleurian AA; Favrel-Feuillade F; Hounliasso I; Lechat P; Luigi E; Mairot L; Nguyen T; Piazza L; Roussel C; Vienney C
    Therapie; 2017 Feb; 72(1):115-123. PubMed ID: 28189333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in clinical testing of medical devices for Europe 1992.
    Reneman RS
    Eur J Cardiothorac Surg; 1992; 6 Suppl 1():S102-6. PubMed ID: 1389268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?
    Chassagnol F; Marcelli G; Wagle J; Giuliani G; Traub D; Schaub V; Ruof J
    Health Policy; 2020 Sep; 124(9):943-951. PubMed ID: 32622542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE.
    Oyebode O; Garrett Z; George E; Cangini A; Muscolo LA; Warren S; Nemeth B; Földesi C; Heislerová M; Gajdošová E
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):59-67. PubMed ID: 26168803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA.
    Kristensen FB; Husereau D; Huić M; Drummond M; Berger ML; Bond K; Augustovski F; Booth A; Bridges JFP; Grimshaw J; IJzerman MJ; Jonsson E; Ollendorf DA; Rüther A; Siebert U; Sharma J; Wailoo A
    Value Health; 2019 Jan; 22(1):13-20. PubMed ID: 30661627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy.
    Migliore A; Ratti M; Cerbo M; Jefferson T
    Expert Rev Med Devices; 2009 May; 6(3):251-7. PubMed ID: 19419283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.